Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Identification of intrinsic determinants of midbrain dopamine neurons.

Andersson E, Tryggvason U, Deng Q, Friling S, Alekseenko Z, Robert B, Perlmann T, Ericson J.

Cell. 2006 Jan 27;124(2):393-405.

2.

Molecular programming of stem cells into mesodiencephalic dopaminergic neurons.

Burbach JP, Smidt MP.

Trends Neurosci. 2006 Nov;29(11):601-3. Review.

PMID:
17030431
3.

Genetic networks controlling the development of midbrain dopaminergic neurons.

Prakash N, Wurst W.

J Physiol. 2006 Sep 1;575(Pt 2):403-10. Review.

4.

A Wnt signal regulates stem cell fate and differentiation in vivo.

Prakash N, Wurst W.

Neurodegener Dis. 2007;4(4):333-8. Review.

PMID:
17627138
5.

Stem cell potential in Parkinson's disease and molecular factors for the generation of dopamine neurons.

Kim HJ.

Biochim Biophys Acta. 2011 Jan;1812(1):1-11. doi: 10.1016/j.bbadis.2010.08.006. Review.

6.

Midbrain dopamine neuron differentiation: factors and fates.

Abeliovich A, Hammond R.

Dev Biol. 2007 Apr 15;304(2):447-54. Review.

7.

The role of Pitx3 in survival of midbrain dopaminergic neurons.

Smits SM, Smidt MP.

J Neural Transm Suppl. 2006;(70):57-60. Review.

PMID:
17017509
8.

Transcriptional control of dopamine neuron development.

Wallén A, Perlmann T.

Ann N Y Acad Sci. 2003 Jun;991:48-60. Review.

PMID:
12846973
9.

Transcriptional control of midbrain dopaminergic neuron development.

Ang SL.

Development. 2006 Sep;133(18):3499-506. Review.

10.

Progressive loss of dopaminergic neurons in the ventral midbrain of adult mice heterozygote for Engrailed1: a new genetic model for Parkinson's disease?

Le Pen G, Sonnier L, Hartmann A, Bizot JC, Trovero F, Krebs MO, Prochiantz A.

Parkinsonism Relat Disord. 2008;14 Suppl 2:S107-11. doi: 10.1016/j.parkreldis.2008.04.007. Review.

PMID:
18585951
11.

Stem cell therapy for Parkinson's disease.

Takahashi J.

Ernst Schering Res Found Workshop. 2006;(60):229-44. Review.

PMID:
16903426
12.

Genetic control of basal midbrain development.

Puelles E.

J Neurosci Res. 2007 Dec;85(16):3530-4. Review.

PMID:
17549729
13.

Wnt/β-catenin signaling in midbrain dopaminergic neuron specification and neurogenesis.

Joksimovic M, Awatramani R.

J Mol Cell Biol. 2014 Feb;6(1):27-33. doi: 10.1093/jmcb/mjt043. Review.

14.

Neuronal cell replacement in Parkinson's disease.

Hedlund E, Perlmann T.

J Intern Med. 2009 Oct;266(4):358-71. doi: 10.1111/j.1365-2796.2009.02155.x. Review.

15.

Development of the dopaminergic neurons in the rodent brainstem.

Vitalis T, Cases O, Parnavelas JG.

Exp Neurol. 2005 Feb;191 Suppl 1:S104-12. Review.

PMID:
15629757
16.

En1 and Wnt signaling in midbrain dopaminergic neuronal development.

Alves dos Santos MT, Smidt MP.

Neural Dev. 2011 May 10;6:23. doi: 10.1186/1749-8104-6-23. Review.

17.

Potential sources of stem cells as a regenerative therapy for Parkinson's disease.

El-Sadik AO.

Stem Cells Cloning. 2010 Dec 6;3:183-91. doi: 10.2147/SCCAA.S14626. Review.

18.

Transcriptional regulation of their survival: the Engrailed homeobox genes.

Simon HH, Alavian KN.

Adv Exp Med Biol. 2009;651:66-72. Review. No abstract available.

PMID:
19731551
19.

Dopamine concentration in the cytoplasmic compartment of single neurons determined by capillary electrophoresis.

Olefirowicz TM, Ewing AG.

J Neurosci Methods. 1990 Sep;34(1-3):11-5. Review.

PMID:
2259233
Items per page

Supplemental Content

Support Center